Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06981156 · ClinicalTrials.gov registry record
Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)
A clinical trial of Pediatric Brain Tumor and Pediatric Spine Tumor, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT06981156 is a study of Pediatric Brain Tumor and Pediatric Spine Tumor that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 75 participants, above the 37-participant average among 9 other Pediatric Brain Tumor trials with a reported enrollment target (103% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06981156, a study of Pediatric Brain Tumor and Pediatric Spine Tumor, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST pNANO Assessment
Study Locations (1)
Wisconsin
- American Family Children's Hospital - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-05-13 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06981156
The ClinicalTrials.gov registry entry for NCT06981156 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 37-participant average among 9 other Pediatric Brain Tumor trials with a reported enrollment target (103% higher). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pediatric Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which pNANO Assessment is the first listed.
NCT06981156 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06981156 about?
NCT06981156 is a clinical study titled "Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)". This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.
What is the current status of trial NCT06981156?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2025-05-13. Estimated completion is 2027-01.
What conditions does trial NCT06981156 study?
This clinical trial studies the following conditions: Pediatric Brain Tumor, Pediatric Spine Tumor.
What interventions are being tested in trial NCT06981156?
The interventions under investigation include: pNANO Assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06981156?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06981156 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Survivors Journey+
RECRUITING · NA
-
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors
RECRUITING · Phase 1
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
RECRUITING · Phase 1
-
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
RECRUITING · NA
-
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.